| OCR Text |
Show No sign of rejection in Brent's transplant, say Seattle doctors Brent Bloomenthal continued to show no evidence of rejection in his bone-marrow transplant this week, although he suffered a slight fever that doctors were monitoring close-' ly. The Park City kindergartener underwent an experimental bone-marrow bone-marrow transplant Dec. 4 as a last-chance last-chance treatment for. his neuroblastoma form of cancer. The Park City community raised more than $50,000 to help finance the procedure pro-cedure in Seattle. "He has a slight fever that they're watching very closely.' said Emmit - Glanz, spokesman for the Hutchinson Hutchin-son Cancer Research Center. "Having "Hav-ing a fever is a pretty common post-transplant post-transplant problem and that's the reason we keep them in the area for 100 days post-transplant." Glanz said that when a patient undergoes a bone-marrow transplant, it takes a while for the lerson's immune system to recover and be able to fight infection. Brent underwent intense chemotherapy and radiation doses in hopes of killing the cancer in his body. But in doing so, his bone mar row was desiroyed, necessitating a transplant. The donor was Brent's half-brother, Ron. Bone marrow produces infection-fighting infection-fighting blood components, red blood cells and platelets, which promote pro-mote blood clotting. "There is no indication of graft-vs.-host disease at this point and so you'd have to say he's really doing well." ; : Brent had been making short lorays out of the hospital with his father, but those were stopped when the fever began early this week, Glanz said. |
